Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

885
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
885
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

2.0K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.0K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

2.7K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.7K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

3.8K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.8K
Local Anesthetics: Chemistry and Structure-Activity Relationship01:30

Local Anesthetics: Chemistry and Structure-Activity Relationship

6.3K
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spirooxindoles as Disruptors of Preformed Hen Egg White Lysozyme Fibrils as a Model for Neurodegenerative Diseases.

ChemMedChem·2026
Same author

Molecular Frameworks for ERK1/2 Inhibition: Lessons from Synthetic and SAR Explorations.

ACS omega·2026
Same author

Correlating Nanomechanical Behavior and Adsorption Performance in a Serendipitously Assembled Two-Dimensional Hydrogen-Bonded Organic System.

Langmuir : the ACS journal of surfaces and colloids·2025
Same author

From bench to bedside: The evolution of extracellular vesicle diagnostics through microfluidic and paper-based technologies.

Colloids and surfaces. B, Biointerfaces·2025
Same author

Solar Cell Enhancement from Supercritical CO<sub>2</sub> Dye Surface Modification of Mesoporous TiO<sub>2</sub> Photoanodes.

ChemSusChem·2024
Same author

Thiazolotriazoles As Anti-infectives: Design, Synthesis, Biological Evaluation and <i>In Silico</i> Studies.

ACS omega·2024

Related Experiment Video

Updated: Jan 10, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.1K

Thiazolotriazoles: Their Biological Activity and Structure-Activity Relationships.

Umadevi Kizhakke Purakkel1,2, Ganji Praveena3, Ewan W Blanch1

  • 1Applied Chemistry and Environmental Science, STEM College, RMIT University, Melbourne, Australia.

Chemical Record (New York, N.Y.)
|November 28, 2025
PubMed
Summary

Thiazolotriazoles are versatile medicinal compounds with broad biological activities, including significant anticancer potential. This review highlights their structure-activity relationships and drug targets, aiding future drug design.

Keywords:
biological activitydrug discoverydrug targetsstructure–activity relationshipsthiazolotriazole

More Related Videos

Author Spotlight: Functionalizing Metal-Organic Frameworks: Advancements, Challenges, and the Power of Post-Synthetic Ligand Exchange
04:51

Author Spotlight: Functionalizing Metal-Organic Frameworks: Advancements, Challenges, and the Power of Post-Synthetic Ligand Exchange

Published on: June 23, 2023

4.1K
Author Spotlight: A New and Efficient Method for Comprehensive Metabolite Cytotoxicity Assessment of Triazole Pesticides in Plants
08:22

Author Spotlight: A New and Efficient Method for Comprehensive Metabolite Cytotoxicity Assessment of Triazole Pesticides in Plants

Published on: December 22, 2023

1.0K

Related Experiment Videos

Last Updated: Jan 10, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.1K
Author Spotlight: Functionalizing Metal-Organic Frameworks: Advancements, Challenges, and the Power of Post-Synthetic Ligand Exchange
04:51

Author Spotlight: Functionalizing Metal-Organic Frameworks: Advancements, Challenges, and the Power of Post-Synthetic Ligand Exchange

Published on: June 23, 2023

4.1K
Author Spotlight: A New and Efficient Method for Comprehensive Metabolite Cytotoxicity Assessment of Triazole Pesticides in Plants
08:22

Author Spotlight: A New and Efficient Method for Comprehensive Metabolite Cytotoxicity Assessment of Triazole Pesticides in Plants

Published on: December 22, 2023

1.0K

Area of Science:

  • Medicinal Chemistry
  • Heterocyclic Chemistry
  • Drug Discovery

Background:

  • Thiazolotriazole, a fused heterocyclic system of 1,3-thiazole and 1,2,4-triazole, exhibits diverse biological activities.
  • Derivatives are explored for antibacterial, anticancer, anti-inflammatory, antifungal, analgesic, anticonvulsant, antidiabetic, and antioxidant properties.
  • These compounds show potential in inhibiting key enzymes like carbonic anhydrase and cyclooxygenase.

Purpose of the Study:

  • To review the biological activities of thiazolotriazole derivatives.
  • To emphasize the structure-activity relationships (SAR) of these compounds.
  • To identify drug targets for specific diseases and guide future drug design.

Main Methods:

  • Review of existing literature on thiazolotriazole synthesis and biological evaluation.
  • Analysis of structure-activity relationships based on reported data.
  • Identification of specific molecular targets and pathways involved in thiazolotriazole's efficacy.

Main Results:

  • Thiazolotriazoles demonstrate significant potential as anticancer agents by targeting apoptosis and proliferation pathways.
  • Compounds exhibit a wide range of activities, including enzyme inhibition relevant to various diseases.
  • SAR analysis provides insights into optimizing molecular structures for enhanced therapeutic effects.

Conclusions:

  • Thiazolotriazole scaffolds are promising for developing novel therapeutics across various disease areas.
  • Understanding SAR is crucial for rational drug design and optimization of thiazolotriazole-based drugs.
  • Further research into specific drug targets will accelerate the development of effective thiazolotriazole medications.